Adverum Biotechnologies, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
BML CAPITAL MANAGEMENT, LLC | 05/07/2025 | 2.74 M | $11.98 M | 20.91% | 13.10% |
TCG CROSSOVER MANAGEMENT, LLC | 05/14/2025 | 1.80 M | $7.85 M | 0.00% | 8.58% |
FRANKLIN RESOURCES INC | 05/13/2025 | 1.76 M | $7.69 M | 0.00% | 8.41% |
04/11/2025 | 1.70 M | $6.07 M | 27.52% | 8.10% | |
BLACKROCK, INC. | 05/02/2025 | 1.43 M | $6.24 M | -3.93% | 6.81% |
FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 05/15/2025 | 1.07 M | $4.67 M | 0.00% | 5.11% |
VANGUARD GROUP INC | 05/09/2025 | 1.03 M | $4.50 M | -0.17% | 4.92% |
GOLDMAN SACHS GROUP INC | 05/16/2025 | 460.83 K | $2.01 M | -7.96% | 2.20% |
GEODE CAPITAL MANAGEMENT, LLC | 05/13/2025 | 451.26 K | $1.97 M | 1.98% | 2.16% |
PALE FIRE CAPITAL SE | 05/14/2025 | 368.27 K | $1.61 M | 16.85% | 1.76% |
STATE STREET CORP | 05/15/2025 | 363.97 K | $1.59 M | -1.51% | 1.74% |
DIMENSIONAL FUND ADVISORS LP | 05/13/2025 | 287.79 K | $1.26 M | -7.46% | 1.37% |
SOLEUS CAPITAL MANAGEMENT, L.P. | 05/15/2025 | 287.25 K | $1.26 M | 0.00% | 1.37% |
REGENERON PHARMACEUTICALS, INC. | 05/02/2025 | 180.91 K | $790.57 K | 0.00% | 0.86% |
WAVERLY ADVISORS, LLC | 05/15/2025 | 160.17 K | $699.92 K | 100.00% | 0.76% |
GRANT/GROSSMENDELSOHN, LLC | 05/01/2025 | 160.16 K | $461.25 K | 90.27% | 0.76% |
RENAISSANCE TECHNOLOGIES LLC | 05/14/2025 | 159.57 K | $697.32 K | 23.12% | 0.76% |
NORTHERN TRUST CORP | 05/13/2025 | 150.37 K | $657.13 K | -1.45% | 0.72% |
MORGAN STANLEY | 05/15/2025 | 68.72 K | $300.30 K | -40.14% | 0.33% |
UBS GROUP AG | 05/13/2025 | 57.55 K | $251.49 K | 20.91% | 0.27% |
BANK OF AMERICA CORP /DE/ | 05/15/2025 | 51.22 K | $223.84 K | 17.55% | 0.24% |
INVESCO LTD. | 05/12/2025 | 49.83 K | $217.76 K | 100.00% | 0.24% |
BANK OF NEW YORK MELLON CORP | 04/29/2025 | 49.32 K | $215.55 K | 2.05% | 0.24% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 05/09/2025 | 49.02 K | $214.24 K | -17.93% | 0.23% |
QUINN OPPORTUNITY PARTNERS LLC | 05/14/2025 | 41.42 K | $181.00 K | 54.38% | 0.20% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/14/2025 | 37.33 K | $163.15 K | 100.00% | 0.18% |
AQR CAPITAL MANAGEMENT LLC | 05/15/2025 | 33.82 K | $147.81 K | 100.00% | 0.16% |
RHUMBLINE ADVISERS | 05/29/2025 | 33.00 K | $144.20 K | 4.21% | 0.16% |
05/12/2025 | 31.85 K | $139.17 K | 100.00% | 0.15% | |
BARCLAYS PLC | 05/15/2025 | 29.51 K | $129.00 K | -26.02% | 0.14% |
D. E. SHAW & CO., INC. | 05/15/2025 | 26.94 K | $117.75 K | -43.41% | 0.13% |
TREXQUANT INVESTMENT LP | 05/14/2025 | 18.69 K | $81.69 K | -80.53% | 0.09% |
AMERICAN CENTURY COMPANIES INC | 05/13/2025 | 17.65 K | $77.12 K | 8.42% | 0.08% |
CANTOR FITZGERALD, L. P. | 05/15/2025 | 15.45 K | $67.50 K | 0.00% | 0.07% |
CITIGROUP INC | 05/12/2025 | 14.75 K | $64.47 K | -26.19% | 0.07% |
FMR LLC | 05/12/2025 | 13.47 K | $58.86 K | -76.74% | 0.06% |
MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 05/15/2025 | 12.62 K | $55.14 K | 4.52% | 0.06% |
WELLS FARGO & COMPANY/MN | 05/13/2025 | 12.53 K | $54.76 K | 2.38% | 0.06% |
INTECH INVESTMENT MANAGEMENT LLC | 05/20/2025 | 12.40 K | $54.19 K | 100.00% | 0.06% |
CAPTRUST FINANCIAL ADVISORS | 05/15/2025 | 10.62 K | $46.43 K | 100.00% | 0.05% |
JPMORGAN CHASE & CO | 05/12/2025 | 10.20 K | $44.57 K | -66.74% | 0.05% |
COREBRIDGE FINANCIAL, INC. | 05/14/2025 | 10.19 K | $44.54 K | -1.46% | 0.05% |
CITADEL ADVISORS LLC | 05/15/2025 | 7.60 K | $33.21 K | -25.49% | 0.04% |
CITADEL ADVISORS LLC | 05/15/2025 | 6.10 K | $26.66 K | -36.46% | 0.03% |
SIMPLEX TRADING, LLC | 05/12/2025 | 4.31 K | $18.00 K | 116.30% | 0.02% |
05/09/2025 | 4.18 K | $18.28 K | 0.00% | 0.02% | |
NEW YORK STATE COMMON RETIREMENT FUND | 05/01/2025 | 3.00 K | $13.00 K | 0.00% | 0.01% |
ROYAL BANK OF CANADA | 05/15/2025 | 2.55 K | $11.00 K | -28.21% | 0.01% |
TOWER RESEARCH CAPITAL LLC (TRC) | 05/15/2025 | 2.40 K | $10.11 K | -44.93% | 0.01% |
AMERITAS INVESTMENT PARTNERS, INC. | 05/12/2025 | 2.04 K | $8.91 K | 0.00% | 0.01% |
Adverum Biotechnologies, Inc. institutional Ownership - FAQ's
During the previous two years, 101 institutional investors and hedge funds held shares of Adverum Biotechnologies, Inc.. The most heavily invested institutionals were:
BML Capital Management, LLC: 2.74 M
TCG Crossover Management, LLC: 1.8 M
FRANKLIN RESOURCES INC: 1.76 M
BlackRock, Inc.: 1.43 M
Frazier Life Sciences Management, L.P.: 1.07 M
VANGUARD GROUP INC: 1.03 M
73.02% of Adverum Biotechnologies, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 31.42 M shares in the last 24 months. This purchase volume represents approximately $70.07 M in transactions.